PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedicine, Aarhus University, Aarhus C 8000, Denmark.\', \'Center for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, Ontario K1H 8L6, Canada.\', \'Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario K1H 8L1, Canada.\', \'Center for Infection, Immunity, and Inflammation, University of Ottawa, Ottawa, Ontario K1H 8L1, Canada.\', \'Ottawa Institute of Systems Biology, Ottawa, Ontario K1H 8L1, Canada.\', \'Aarhus Institute of Advanced Studies, Aarhus University, Aarhus 8000, Denmark.\', \'Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, Rome 00161, Italy.\', \'Institut National de la Recherche Scientifique (INRS)-Centre Armand-Frappier Santé Biotechnologie, Laval, Québec H7V 1B7, Canada.\', \'CCFP, Dipl. Sport Med., CareMedics McArthur, 311 McArthur Avenue suite 103, Ottawa, Ontario K1L 8M3, Canada.\', \'Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.\', \'Children\'s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario K1H 8L1, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acsinfecdis.1c00278
?:doi
?:hasPublicationType
?:journal
  • ACS infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34658235
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.618
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all